Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-022-8 | CAS number: 90-87-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 02 January 2019 to 22 January 2019
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 019
- Report date:
- 2019
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5100 - Bacterial Reverse Mutation Test (August 1998)
- Qualifier:
- according to guideline
- Guideline:
- other: Japanese Ministry of Economy, Trade and Industry, Japanese Ministry of Health, Labor and Welfare and Japanese Ministry of Agriculture, Forestry and Fisheries, 24 November 2000
- Qualifier:
- according to guideline
- Guideline:
- other: ICH S2(R1) guideline adopted June 2012 (ICH S2(R1) Federal Register. Adopted 2012; 77:33748-33749)
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- 2-phenylpropionaldehyde-dimethyl acetal
- EC Number:
- 202-022-8
- EC Name:
- 2-phenylpropionaldehyde-dimethyl acetal
- Cas Number:
- 90-87-9
- Molecular formula:
- C11H16O2
- IUPAC Name:
- (1,1-dimethoxypropan-2-yl)benzene
- Test material form:
- liquid
Constituent 1
Method
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- Phenobarbital/beta-Naphtha flavone-induced rat liver S9 mix
- Test concentrations with justification for top dose:
- Experiment 1: 1.5, 5, 15, 50, 150, 500, 1500 and 5000 μg/plate
Experiment 2: 50, 150, 500, 1000, 1500, 3000 and 5000 μg/plate
Experiment 3: 15, 50, 150, 500, 1500 and 5000 μg/plate - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: The test item was immiscible in sterile distilled water at 50 mg/mL but was fully miscible in dimethyl sulphoxide at the same concentration in solubility checks performed in-house. Dimethyl sulphoxide was therefore selected as the vehicle.
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- 9-aminoacridine
- N-ethyl-N-nitro-N-nitrosoguanidine
- benzo(a)pyrene
- other: 2-Aminoanthracene
- Details on test system and experimental conditions:
- METHOD OF APPLICATION:
- Experiment 1 and 2: in agar (plate incorporation)
- Experiment 3: preincubation
DURATION
- Preincubation period: 20 minutes (Experiment 3)
- Exposure duration: 48-72 hours
NUMBER OF REPLICATIONS: 3
DETERMINATION OF CYTOTOXICITY
- Method: The plates were viewed microscopically for evidence of thinning - Evaluation criteria:
- There are several criteria for determining a positive result. Any, one, or all of the following can be used to determine the overall result of the study:
1. A dose-related increase in mutant frequency over the dose range tested (De Serres and Shelby, 1979).
2. A reproducible increase at one or more concentrations.
3. Biological relevance against in-house historical control ranges.
4. A fold increase greater than two times the concurrent solvent control for TA100, TA98 and WP2uvrA or a three-fold increase for TA1535 and TA1537 (especially if accompanied by an out-of-historical range response (Cariello and Piegorsch, 1996)).
5. Statistical analysis of data as determined by UKEMS (Mahon et al., 1989).
A test item will be considered non-mutagenic (negative) in the test system if the above criteria are not met. Although most experiments will give clear positive or negative results, in some instances the data generated will prohibit making a definite judgment about test item activity. Results of this type will be reported as equivocal. - Statistics:
- Statistical significance was confirmed by using Dunnett’s Regression Analysis (p < 0.05) for those values that indicate statistically significant increases in the frequency of revertant colonies compared to the concurrent solvent control.
Results and discussion
Test results
- Key result
- Species / strain:
- bacteria, other: S. typhimurium TA 1535, TA 1537, TA 98 and TA 100 and E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Controls:
- Prior to use, the master strains were checked for characteristics, viability and spontaneous reversion rate (all were found to be satisfactory). The amino acid supplemented top agar and the S9-mix used in both experiments was shown to be sterile. The test item formulation was also shown to be sterile. These data are not given in the report.
- Results for the negative controls (spontaneous mutation rates) are considered to be acceptable.
- The vehicle (dimethyl sulphoxide) control plates gave counts of revertant colonies within the normal range. All of the positive control chemicals used in the test induced marked increases in the frequency of revertant colonies, both with and without metabolic activation. Thus, the sensitivity of the assay and the efficacy of the S9-mix were validated.
Experiment 1:
- There was no visible reduction in the growth of the bacterial background lawn at any dose level, either in the presence or absence of metabolic activation (S9-mix).
- No test item precipitate was observed on the plates at any of the doses tested in either the presence or absence of metabolic activation (S9-mix).
- There were no biologically relevant increases in the frequency of revertant colonies recorded for any of the bacterial strains, with any dose of the test item, either with or without metabolic activation (S9-mix) in Experiment 1 (plate incorporation method). Small, statistically significant increases in TA100 revertant colony frequency were observed at 500, 1500 and 5000 μg/plate in the absence of S9-mix. These increases were within the in-house historical vehicle/untreated control range for the strain and were, therefore considered of no biological relevance. Statistically significant increases in TA1535 revertant colony frequency were also observed at 5000 μg/plate in the absence of S9-mix. Although these counts exceeded the in-house historical untreated/vehicle control range, the increases were still considered to be of no biological relevance because there was no evidence of a dose-response relationship and could not be reproduced in a confirmatory experiment.
Experiment 2:
- There was no visible reduction in the growth of the bacterial background lawn at any dose level, either in the presence or absence of metabolic activation (S9-mix).
- No test item precipitate was observed on the plates at any of the doses tested in either the presence or absence of metabolic activation (S9-mix).
- No biologically relevant increases in the frequency of revertant colonies were recorded for any of the bacterial strains, with any dose of the test item, either with or without metabolic activation (S9-mix) in Experiment 2 (repeat of plate incorporation method). Statistically significant increases in TA100 revertant colony frequency were observed in the second mutation test at 5000 μg/plate in the absence of S9-mix, however this response was within the in-house historical vehicle/untreated control range for the strain and was, therefore considered of no biological relevance.
Experiment 3:
Weakened bacterial background lawns were noted in the third experiment utilizing the pre-incubation modification with a toxic response observed at 5000 μg/plate to all of the tester strains in both the absence and presence of S9-mix.
No test item precipitate was observed on the plates at any of the doses tested in either the presence or absence of metabolic activation (S9-mix).
There were no significant increases in the frequency of revertant colonies recorded for any of the bacterial strains, with any dose of the test item, either with or without metabolic activation (S9-mix).
Any other information on results incl. tables
Table 1: Mean number of revertants without metabolic activation
|
TA100 |
|
|
TA1535 |
|
|
WP2 |
|
|
TA98 |
|
|
TA1537 |
|
|
(µg) |
Exp 1 |
Exp 2 |
Exp 3 |
Exp 1 |
Exp 2 |
Exp 3 |
Exp 1 |
Exp 2 |
Exp 3 |
Exp 1 |
Exp 2 |
Exp 3 |
Exp 1 |
Exp 2 |
Exp 3 |
Solvent |
106 |
119 |
130 |
20 |
20 |
27 |
24 |
21 |
16 |
19 |
27 |
16 |
11 |
14 |
12 |
1.5 |
123 |
- |
- |
26 |
- |
- |
18 |
- |
- |
18 |
- |
- |
9 |
- |
- |
5 |
100 |
- |
- |
32 |
- |
- |
19 |
- |
- |
21 |
- |
- |
13 |
- |
- |
15 |
96 |
- |
121 |
24 |
- |
27 |
23 |
- |
16 |
21 |
- |
17 |
11 |
- |
16 |
50 |
109 |
123 |
112 |
15 |
19 |
25 |
23 |
26 |
21 |
15 |
19 |
16 |
10 |
14 |
16 |
150 |
106 |
127 |
123 |
39 |
18 |
26 |
22 |
19 |
15 |
17 |
28 |
22 |
13 |
12 |
18 |
500 |
137 |
115 |
113 |
39 |
18 |
19 |
24 |
21 |
14 |
16 |
27 |
15 |
14 |
14 |
12 |
1000 |
- |
132 |
- |
- |
18 |
- |
- |
20 |
- |
- |
21 |
- |
- |
13 |
- |
1500 |
131 |
132 |
117 |
26 |
15 |
11 |
21 |
21 |
16 |
19 |
20 |
12 |
9 |
15 |
8 |
3000 |
- |
137 |
- |
- |
13 |
- |
- |
17 |
- |
- |
17 |
- |
- |
9 |
- |
5000 |
145 |
140 |
108 |
68 |
17 |
13 |
21 |
17 |
0 |
16 |
19 |
12 |
14 |
7 |
8 |
Table 2: Mean number of revertants with metabolic activation
|
TA100 |
|
|
TA1535 |
|
|
WP2 |
|
|
TA98 |
|
|
TA1537 |
|
|
(µg) |
Exp 1 |
Exp 2 |
Exp 3 |
Exp 1 |
Exp 2 |
Exp 3 |
Exp 1 |
Exp 2 |
Exp 3 |
Exp 1 |
Exp 2 |
Exp 3 |
Exp 1 |
Exp 2 |
Exp 3 |
Solvent |
111 |
130 |
121 |
11 |
18 |
26 |
25 |
28 |
24 |
25 |
26 |
31 |
15 |
11 |
15 |
1.5 |
101 |
- |
- |
14 |
- |
- |
30 |
- |
- |
25 |
- |
- |
14 |
- |
- |
5 |
109 |
- |
- |
11 |
- |
- |
26 |
- |
- |
24 |
- |
- |
9 |
- |
- |
15 |
110 |
- |
104 |
14 |
- |
22 |
26 |
- |
25 |
19 |
- |
25 |
10 |
- |
13 |
50 |
114 |
138 |
120 |
16 |
12 |
21 |
23 |
22 |
31 |
19 |
35 |
25 |
10 |
14 |
9 |
150 |
128 |
129 |
128 |
13 |
18 |
21 |
28 |
27 |
23 |
22 |
25 |
25 |
14 |
11 |
9 |
500 |
123 |
123 |
129 |
20 |
15 |
22 |
33 |
36 |
23 |
22 |
33 |
23 |
12 |
9 |
10 |
1000 |
- |
117 |
- |
- |
15 |
- |
- |
23 |
- |
- |
25 |
- |
- |
12 |
- |
1500 |
114 |
134 |
116 |
8 |
16 |
12 |
30 |
19 |
21 |
26 |
32 |
25 |
12 |
13 |
7 |
3000 |
- |
132 |
- |
- |
10 |
- |
- |
17 |
- |
- |
32 |
- |
- |
11 |
- |
5000 |
97 |
134 |
85 |
9 |
9 |
8 |
25 |
17 |
14 |
19 |
25 |
11 |
8 |
6 |
6 |
Applicant's summary and conclusion
- Conclusions:
- The test material was considered non-mutagenic under the conditions of this test.
- Executive summary:
The test substance was evaluated in a bacterial reverse mutation assay performed according to OECD 471 and following GLP using Salmonella typhimurium strains TA98, TA100, TA 1535 and TA1537 and Escherichia coli strain WP2 uvrA both in the presence and absence of an exogenous metabolic activation system (S9 -mix). In the first experiment, test substance concentrations of 1.5, 5, 15, 50, 150, 500, 1500 and 5000 μg/plate were assessed using the plate incorporation assay in triplicate. A small, statistical response was noted for TA1535 in Experiment 1, therefore the experiment was repeated using test concentrations of 50, 150, 500, 1000, 1500, 3000 and 5000 μg/plate. There were no statistically significant increases noted to TA1535 in Experiment 2, therefore, a third, confirmatory experiment was performed using the preincubation method at test concentrations of 15, 50, 150, 500, 1500 and 5000 μg/plate. The vehicle (dimethyl sulphoxide) control plates gave counts of revertant colonies within the normal range. All of the positive control chemicals used in the test induced marked increases in the frequency of revertant colonies, both with and without metabolic activation. Thus, the sensitivity of the assay and the efficacy of the S9-mix were validated. In the first and second mutation test, the test item induced no visible reduction in the bacterial background lawns of any tester strains. In experiment 3, weakened bacterial background lawns were noted at 5000 μg/plate to all of the tester strains in both the absence and presence of S9-mix. No test item precipitate was observed on any of the plates. There were no biologically relevant increases in the frequency of revertant colonies recorded for any of the bacterial strains, with any dose of the test item, either with or without metabolic activation (S9-mix) in Experiment 1. Small, statistically significant increases in TA100 revertant colony frequency were observed in the first mutation test at 500, 1500 and 5000 μg/plate in the absence of S9-mix. These increases were within the in-house historical vehicle/untreated control range for the strain and were, therefore considered of no biological relevance. Statistically significant increases in TA1535 revertant colony frequency were also observed in the first mutation test at 5000 μg/plate in the absence of S9-mix. Although these counts exceeded the in-house historical untreated/vehicle control range, the increases were still considered to be of no biological relevance because there was no evidence of a dose-response relationship and could not be reproduced in further experiments. In the second experiment, no biologically relevant increases in the frequency of revertant colonies were recorded for any of the bacterial strains, with any dose of the test item, either with or without metabolic activation. Statistically significant increases in TA100 revertant colony frequency were observed in the second mutation test at 5000 μg/plate in the absence of S9-mix, however this response was within the in-house historical vehicle/untreated control range for the strain and was, therefore considered of no biological relevance. In experiment 3, no significant increases in the frequency of revertant colonies were recorded for any of the bacterial strains, with any dose of the test item, either with or without metabolic activation. Although the increases noted for TA1535 in Experiment 1 were quite large (3.5 fold the concurrent vehicle control), they were considered to be of no biological relevance because they could not be reproduced in two further experiments (one of which contained intermediate test item concentration levels in an attempt to qualify the response). There were many different sized colonies noted at the statistically significant dose level (5000 μg/plate) and there may have been an issue with underlying contamination but it was considered that the results should be confirmed in further tests. Therefore, the test material was considered to be non-mutagenic under the conditions of this test.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.